CellaVision AB Statistics
Total Valuation
CellaVision AB has a market cap or net worth of 399.56 million. The enterprise value is 386.92 million.
| Market Cap | 399.56M |
| Enterprise Value | 386.92M |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 19.82M |
Valuation Ratios
The trailing PE ratio is 31.42.
| PE Ratio | 31.42 |
| Forward PE | n/a |
| PS Ratio | 6.11 |
| PB Ratio | 5.42 |
| P/TBV Ratio | 7.42 |
| P/FCF Ratio | 23.72 |
| P/OCF Ratio | 22.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.75, with an EV/FCF ratio of 22.97.
| EV / Earnings | 30.43 |
| EV / Sales | 5.19 |
| EV / EBITDA | 17.75 |
| EV / EBIT | 21.11 |
| EV / FCF | 22.97 |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.69 |
| Quick Ratio | 2.51 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.14 |
| Interest Coverage | 94.21 |
Financial Efficiency
Return on equity (ROE) is 18.37% and return on invested capital (ROIC) is 13.68%.
| Return on Equity (ROE) | 18.37% |
| Return on Assets (ROA) | 11.44% |
| Return on Invested Capital (ROIC) | 13.68% |
| Return on Capital Employed (ROCE) | 19.66% |
| Revenue Per Employee | 298,388 |
| Profits Per Employee | 58,060 |
| Employee Count | 219 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.31% in the last 52 weeks. The beta is 1.23, so CellaVision AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | +15.31% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 45.66 |
| Average Volume (20 Days) | 535 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellaVision AB had revenue of 65.35 million and earned 12.72 million in profits. Earnings per share was 0.53.
| Revenue | 65.35M |
| Gross Profit | 44.01M |
| Operating Income | 16.05M |
| Pretax Income | 15.98M |
| Net Income | 12.72M |
| EBITDA | 18.01M |
| EBIT | 16.05M |
| Earnings Per Share (EPS) | 0.53 |
Balance Sheet
The company has 13.50 million in cash and 2.43 million in debt, giving a net cash position of 11.08 million.
| Cash & Cash Equivalents | 13.50M |
| Total Debt | 2.43M |
| Net Cash | 11.08M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 73.71M |
| Book Value Per Share | 3.09 |
| Working Capital | 26.54M |
Cash Flow
In the last 12 months, operating cash flow was 17.93 million and capital expenditures -1.08 million, giving a free cash flow of 16.85 million.
| Operating Cash Flow | 17.93M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | 16.85M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.35%, with operating and profit margins of 24.57% and 19.46%.
| Gross Margin | 67.35% |
| Operating Margin | 24.57% |
| Pretax Margin | 24.45% |
| Profit Margin | 19.46% |
| EBITDA Margin | 27.56% |
| EBIT Margin | 24.57% |
| FCF Margin | 25.78% |
Dividends & Yields
CellaVision AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 38.14% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 3.18% |
| FCF Yield | 4.22% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CellaVision AB has an Altman Z-Score of 20.4.
| Altman Z-Score | 20.4 |
| Piotroski F-Score | n/a |